Corvus Pharmaceuticals, Inc. CRVS

Updated: 16 Jun 2026

NASDAQ | Biotech | Immuno-oncology and immunology biopharmaceuticals

No signal published yet

We already track Corvus Pharmaceuticals and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Corvus Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Immuno-oncology and immunology biopharmaceuticals
We're already tracking Corvus Pharmaceuticals, Inc. — here are the latest events we've registered

Recent News

  • On June 9, 2026, Corvus announced an additional investment in Angel Pharmaceuticals to support the development of soquelitinib in China for atopic dermatitis and asthma. The company also presented Phase 1 data for soquelitinib in atopic dermatitis at the Society for Investigative Dermatology annual meeting in May 2026.

What Firelda Watch includes for Corvus Pharmaceuticals, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Corvus Pharmaceuticals, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Exelixis, Inc.
EXEL
HOLD
Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL

Biotech

More companies in this sector

Want to follow Corvus Pharmaceuticals, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Corvus Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Corvus Pharmaceuticals, Inc. CRVS
Corvus Pharmaceuticals — follow and we'll monitor it
Follow Corvus Pharmaceuticals free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.